AMN Healthcare announced its third quarter 2024 financial results, with consolidated revenue of $688 million. GAAP EPS was $0.18, and adjusted EPS was $0.61. The company is innovating with clients and healthcare partners to optimize their workforce.
Consolidated revenue for the quarter was $688 million, a 19% decrease from prior year and a 7% decrease from the prior quarter.
Net income was $7 million (1.0% of revenue), or $0.18 per diluted share, compared with $53 million (6.2% of revenue), or $1.39 per diluted share, in the third quarter of 2023.
Adjusted diluted EPS in the third quarter was $0.61 compared with $1.97 in the same quarter a year ago.
At September 30, 2024, cash and cash equivalents totaled $31 million.
Revenue in the fourth quarter of 2024 is expected to be 14-16% lower than the prior year and flat to up 3% sequentially.
Visualization of income flow from segment revenue to net income